Published in

Elsevier, The Lancet Diabetes and Endocrinology, 1(12), p. 51-60, 2024

DOI: 10.1016/s2213-8587(23)00322-4

Links

Tools

Export citation

Search in Google Scholar

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

Journal article published in 2024 by Pk Judge, N. Staplin, Kj Mayne, C. Wanner, Jb Green, Sj Hauske, Jr Emberson, D. Preiss, Sya Ng, Aj Roddick, E. Sammons, D. Zhu, M. Hill, W. Stevens, K. Wallendszus and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO